OFFICIAL NOTICE CONTENT
Opportunity description
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00027. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Integrated DNA Technologies, Inc. (IDT), 1710 Commercial Park, Coralville, IA 52241, for custom-designed ArcherDX VariantPlex Next-Generation Sequencing (NGS) target-enrichment library preparation kits. Integrated DNA Technologies, Inc. is the sole owner, manufacturer, and distributor of the proprietary ArcherDX VariantPlex Anchored Multiplex PCR (AMP) chemistry, which has been utilized by the NHLBI Hematology Branch since 2019 to perform error-correcting sequencing (ECS) and is required to maintain scientific continuity, prevent technical batch effects across longitudinal patient cohorts, and ensure compatibility with the laboratory�s established Archer Analysis bioinformatics pipeline. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) and the small business size standard is 1,250 employees. This requirement is not set aside for small business.
FEDERAL BUYER
Buyer and contracting office
Public points of contact
DOCUMENTS & LINKS
Opportunity documents
That does not mean there are no documents. Open the current SAM.gov notice to see the authoritative attachment and amendment list.
GovBidFit does not invent or cache guessed attachment links. The official SAM.gov notice remains the controlling document source.
NOTICE TIMELINE
GovBidFit change history
This timeline records when GovBidFit first stored the notice and material field changes detected during scheduled SAM.gov refreshes. It is an audit aid, not a substitute for the official amendment history.
GovBidFit first stored this opportunity from the SAM.gov public bulk feed. This does not replace the official posting date shown above.
GOVBIDFIT SCREENING LENS
What deserves attention before you spend bid time
These screening signals are generated from the public notice fields stored for this specific opportunity. They are not eligibility findings or predictions; they are prompts for a faster, more disciplined review of the official solicitation.
This record is in a solicitation stage, so submission instructions, evaluation factors, attachments and amendments should be reviewed before a bid/no-bid decision.
The stored deadline is within three days. Check earlier question, site-visit and attachment requirements immediately; the final response date may not be the first deadline that matters.
The current feed does not show a program-specific set-aside restriction. That does not remove other eligibility, responsibility, registration or solicitation-specific requirements.
NAICS 325413 · PSC 6550 is the recorded classification. Use it as a screening clue, then compare the actual scope and deliverables rather than treating the code alone as proof of fit.
GovBidFit stores 2 notices tied to this solicitation. Review the notice chain and official SAM.gov history because later postings can change dates, scope or instructions.
GovBidFit stores the source notice text, but its length does not prove the requirements are complete. Review official attachments, clauses, amendments and Q&A before relying on the description.
The source data includes 1 public contracting contact. Use the solicitation's stated communication rules and deadlines before contacting the buyer.
Questions to resolve next
What this opportunity record tells you
SAM.gov identifies this as a combined synopsis/solicitation from HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The record was posted on November 2, 2026 and currently lists November 5, 2026 as the response deadline. GovBidFit keeps source facts separate from its matching guidance so you can see what comes from the federal notice.
The listed product or service classification is NAICS 325413 · In-Vitro Diagnostic Substance Manufacturing · PSC 6550. The set-aside field is Unrestricted. These fields help narrow your search, but they do not replace the full solicitation, amendments, attachments, clauses or eligibility language on the official source.
Before deciding to bid
GovBidFit lets you browse federal contract opportunities for free and create free bid alerts. It displays public SAM.gov notice data stored in its database, with a compact snapshot as a fallback. GovBidFit is independent and is not a U.S. government website. Data can lag amendments or later source changes, so always verify the current notice, attachments and deadline on SAM.gov before bidding.
Open the official SAM.gov notice →